Insights: Pancreatic Cancer — Designing new treatments for a deadly cancer

Pancreatic cancer remains one of the deadliest cancers for which there is no current effective treatment.

Only one in ten people survive longer than five years, according to the American Cancer Society, and its incidence is on the rise. It is predicted to become the second-leading cause of cancer-related deaths in the U.S. by 2030.

Join Cosimo Commisso, Ph.D., Director of the Cell and Molecular Biology of Cancer Program at Sanford Burnham Prebys, and learn about promising research breakthroughs toward effective treatments for pancreatic cancer:

Learn about the Commisso lab’s original research on the way nutrient metabolism in pancreatic tumors supports tumor growth and spread. Drugs that target cancer metabolism may help starve tumors to death
Understand how disrupting the pH balance of pancreatic cells can promote cancer cell death—a novel research approach to treating pancreatic cancer
Hear about two novel cancer drug discovery projects that hold promise to help stop pancreatic cancer in its tracks
Don’t miss this chance to connect and have your questions answered!